Cas 1245768-75-5,9-(4-(1-aminocyclobutyl)phenyl)-8-phenyl[1,2,4]triazolo[4,3-h]-1,7-naphthyridin-3(2H)-one

1245768-75-5

Post Buying Request

Basic information

Product Name: 9-(4-(1-aminocyclobutyl)phenyl)-8-phenyl[1,2,4]triazolo[4,3-h]-1,7-naphthyridin-3(2H)-one
Synonyms: 9-(4-(1-aminocyclobutyl)phenyl)-8-phenyl[1,2,4]triazolo[4,3-h]-1,7-naphthyridin-3(2H)-one
CAS NO:1245768-75-5
Molecular Formula:
Molecular Weight: 407.475
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 9-(4-(1-aminocyclobutyl)phenyl)-8-phenyl[1,2,4]triazolo[4,3-h]-1,7-naphthyridin-3(2H)-one(CAS DataBase Reference)
NIST Chemistry Reference: 9-(4-(1-aminocyclobutyl)phenyl)-8-phenyl[1,2,4]triazolo[4,3-h]-1,7-naphthyridin-3(2H)-one(1245768-75-5)
EPA Substance Registry System: 9-(4-(1-aminocyclobutyl)phenyl)-8-phenyl[1,2,4]triazolo[4,3-h]-1,7-naphthyridin-3(2H)-one(1245768-75-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1245768-75-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1245768-75-5 Suppliers

Recommended suppliers

1245768-75-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1245768-75-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,5,7,6 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1245768-75:
(9*1)+(8*2)+(7*4)+(6*5)+(5*7)+(4*6)+(3*8)+(2*7)+(1*5)=185
185 % 10 = 5
So 1245768-75-5 is a valid CAS Registry Number.

1245768-75-5Upstream product

1245768-75-5Downstream Products

1245768-75-5Relevant academic research and scientific papers

INHIBITORS OF AKT ACTIVITY

-

Page/Page column 83, (2010/10/03)

The instant invention provides for substituted fused naphthyridine derivatives that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1245768-75-5